Drugs for treatment of peptic ulcers.
D000658:Amoxicillin / Q000627:therapeutic use; D000863:Antacids / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D017291:Clarithromycin / Q000627:therapeutic use; D003967:Diarrhea / Q000139:chemically induced; D004347:Drug Interactions; D004352:Drug Resistance, Microbial; D004381:Duodenal Ulcer / Q000188:drug therapy; D016481:Helicobacter Infections / Q000175:diagnosis; D016480:Helicobacter pylori / Q000302:isolation & purification; D006635:Histamine H2 Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008795:Metronidazole / Q000627:therapeutic use; D016595:Misoprostol / Q000009:adverse effects / Q000627:therapeutic use; D010437:Peptic Ulcer / Q000188:drug therapy*; D054328:Proton Pump Inhibitors; D012459:Salicylates / Q000627:therapeutic use; D020156:Salicylic Acid; D013392:Sucralfate / Q000009:adverse effects / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use
D000863:Antacids; D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents; D006635:Histamine H2 Antagonists; D054328:Proton Pump Inhibitors; D012459:Salicylates; D016595:Misoprostol; D008795:Metronidazole; D013392:Sucralfate; D000658:Amoxicillin; D013752:Tetracycline; D017291:Clarithromycin; D020156:Salicylic Acid